Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrins are a superfamily of cell adhesion heterodimeric transmembrane receptors, each consisting of specific alpha and beta subunits, that mediate cell–cell and cell–extracellular matrix interactions. While presented together in this summary, Integrin alpha-V beta-3, alpha-V beta-5, alpha-5 beta-1, and alpha-M beta-2 receptors are distinct molecular entities with unique binding specificities and tissue distributions. Integrin alpha-V beta-3 and alpha-V beta-5 are RGD-binding receptors recognized for their roles in angiogenesis, tumor invasion, and regulation of cell migration through binding to vitronectin, fibronectin, osteopontin, and other ECM proteins. Integrin alpha-5 beta-1 is the main fibronectin receptor, playing a central role in development, cell adhesion, migration, and ECM structure. Integrin alpha-M beta-2 (Mac-1, CR3) is primarily expressed on myeloid and certain immune cells, mediating leukocyte adhesion, migration, and phagocytosis in inflammation and immune responses. Each integrin plays distinct and overlapping biological roles, and several are actively pursued as drug targets in oncology, fibrosis, and immune-related diseases, although clinical translation has been challenging due to on-target adverse effects and context-specific biology.
Competitive inhibition of ligand (RGD motif-containing proteins like fibronectin or vitronectin) binding Antagonism of integrin-mediated cell adhesion, migration, and survival Modulation or inhibition of downstream signaling pathways involved in proliferation, migration, and immune activation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha-V beta-3, alpha-V beta-5, alpha-5 beta-1, and alpha-M beta-2 receptors (αVβ3, αVβ5, α5β1, αMβ2).